Resultados da pesquisa por Autor

1

A carregar...

Editorial: Advances in The Therapy of Atrial Fibrillation: Incrementally Progressive But Not Without Missteps

Por Reiffel, James A
Publicado em 2014

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

A carregar...

Are we at the Goal Line with the Novel Oral Anticoagulants and Have We Reached the End of the Line for Dronedarone and Vernakalant – or is There More to Come?

Por Reiffel, James A
Publicado em 2014

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

3

A carregar...

Does the FDA Owe Us an Explanation?

Por Reiffel, James A
Publicado no J Atr Fibrillation (2015)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

4

A carregar...

The Power of One: a Highly Detailed, Log-Based, Case Example that Clearly Demonstrates the Effective Use of Ranolazine for the Control of Progressive Atrial Fibrillationn

Por Reiffel, James A
Publicado no J Atr Fibrillation (2010)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

5

A carregar...

The New Novel Oral Anticoagulants (NOACs) In Patients With Atrial Fibrillation: Dogma, Dilemmas, And Decisions On Dosing

Por Reiffel, James A
Publicado no J Atr Fibrillation (2014)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

6

A carregar...

GIANT Flutter Waves in ECG Lead V1: a Marker of Pulmonary Hypertension

Por Reiffel, James A
Publicado no J Atr Fibrillation (2008)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

7

A carregar...

Dronedarone: Where Does it Fit in the AF Therapeutic Armamentarium?

Por Reiffel, James A
Publicado no J Atr Fibrillation (2013)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

8

A carregar...

Dronedarone For Atrial Fibrillation: Unbridled Enthusiasm Or Just Another Small Step Forward?

Por Reiffel, James A
Publicado no J Atr Fibrillation (2009)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

9

A carregar...

Rate Versus Rhythm Control Pharmacotherapy For Atrial Fibrillation: Where are We in 2008?

Por Reiffel, James A
Publicado no J Atr Fibrillation (2008)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

10

A carregar...

The Anticoagulated Atrial Fibrillation Patient Who Requires “Curative” Therapy for Prostate Carcinoma: a Bleeding Conundrum

Por Reiffel, James A
Publicado no J Atr Fibrillation (2008)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

11

A carregar...

Optimum Risk Assessment for Stroke in Atrial Fibrillation: Should We Hold the Status Quo or Consider Magnitude Synergism and Left Atrial Appendage Anatomy?

Por Reiffel, James A
Publicado no Arrhythm Electrophysiol Rev (2017)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

12

A carregar...

Complexities in the Atrial Fibrillation-Stroke Relationship: Improving Comprehension of Temporal Discordance, Magnitude Synergism, and Subclinical Atrial Fibrillation -- Three Sour...

Por Reiffel, James A.
Publicado no J Atr Fibrillation (2018)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

13

A carregar...

Propensity-Score Matching: Optimal, Adequate, or Incomplete?

Por Reiffel, James A.
Publicado no J Atr Fibrillation (2018)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

14

A carregar...

Practical algorithms for pharmacologic management of the post myocardial infarction patient

Por Reiffel, James A.
Publicado no Clin Cardiol (2009)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

15

A carregar...

Reduced-dose Antiarrhythmic Drugs: Valuable or Valueless?

Por Reiffel, James A.
Publicado no J Innov Card Rhythm Manag (2020)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

16

A carregar...

TTR: Time in Therapeutic Range or “The Troublesome Report”?

Por Reiffel, James A.
Publicado no J Innov Card Rhythm Manag (2019)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

17

A carregar...

When Silence Isn’t Golden: The Case of “Silent” Atrial Fibrillation

Por Reiffel, James A.
Publicado no J Innov Card Rhythm Manag (2017)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

18

A carregar...

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation

Por Reiffel, James A.
Publicado no J Innov Card Rhythm Manag (2018)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

19

A carregar...

Considerations Regarding the Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation

Por Reiffel, James A.
Publicado no J Innov Card Rhythm Manag (2018)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

20

A carregar...

Oral Anticoagulant Therapy: When What Should Not Be Is and What Should Be Is Not

Por Reiffel, James A.
Publicado no J Innov Card Rhythm Manag (2019)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

Refinar a Pesquisa